The World Health Organization confirmed that the results of the first phase that exceeded the University of Oxford anti-coronavirus vaccine were good and promising, especially with regard to the formation of antibodies, for those who received an enhanced dose of the vaccine and their ages between 18 and 50 years.
Most of these did not suffer from headaches or side effects, but the challenge will be to ensure that enough production is produced for the whole world, said Dr. Mike Ryan, Executive Director of the WHO's emergency program, during a press conference today in Geneva.
The Director General of the organization, Dr. Tedros Adhanum Gabrios, said that ensuring that everyone and the poor in particular have access to the vaccine and distribute it fairly requires political will for leaders. He stressed that ensuring the vaccine reaches everyone is the way to end the epidemic. However, he expressed concern that some countries - which he did not name - were taking the opposite direction.
Tedros urged countries not to wait for the vaccine and to continue to use available tools that have proven effective in controlling and controlling the virus, such as conducting virus detection tests, isolating infected cases and tracing contacts.